Argentina Opens the Door: Why Regulated Nicotine Alternatives Are the Smoke-Free Answer

On 4 May 2026, Argentina made history. After 15 years of prohibition, the country’s Ministry of Health published Resolution 549/2026 in the Official Gazette, formally ending the ban on electronic nicotine delivery systems (ENDS) and nicotine delivery systems (NDS), and for the first time establishing a legal regulatory framework for vaping devices, heated tobacco products, and nicotine pouches.

For the 8.1 million adult smokers in Argentina, which is roughly 22.8% of the adult population, including an estimated 5.2 million daily smokers, this is not just a policy footnote. It is potentially, a life-changing shift in access. Because the central question Argentina’s government has finally answered is one that every public health authority in the world is grappling with: when prohibition demonstrably fails to eliminate a product, and when evidence shows that product can help people move away from something far more deadly, is prohibition still the right policy?

Argentina’s answer is no. And the evidence behind that decision is compelling.

What Resolution 549/2026 Actually Does

Resolution 549/2026 is not a deregulation. It is a reregulation, a deliberate shift from a prohibition model to a structured oversight model. The resolution, signed by the Ministry of Health on 30 April 2026 and effective immediately upon its 4 May publication, does three substantive things.

First, it creates the Tobacco and Nicotine Products Registry (RPTN), a mandatory registration, control, and traceability system covering vaping devices, e-liquids, heated tobacco products and sticks, and nicotine pouches. Every product in these categories must be registered before it can be imported or sold.

Second, it is accompanied by ANMAT Provision 2543/2026, which formally repeals the ban on electronic cigarettes that had been in force since 2011 and extended to heated tobacco products in 2023. The dual mechanism (Ministry resolution plus ANMAT provision) closes the legislative gap that had allowed prohibition to remain intact even as the informal market flourished.

Third, it establishes enforceable quality, ingredient disclosure, and technical standards for all regulated products, while preserving the prohibition on advertising, promotion, and sponsorship under Law 26,687. The framework is compliance-first by design: the market opens not to the loudest brand but to the most documented one.

Crucially, the resolution’s own preamble is candid about why the shift was necessary. It cites data from SEDRONAR’s 2025 national drug survey showing that e-cigarettes and vaping devices rank third among substances consumed by secondary school students, with a 35.5% consumption rate under prohibition. The government’s conclusion, stated plainly: prohibition did not eliminate product use; it displaced it into informal, unregulated, and unverifiable channels.

The Smoking Burden Argentina Can No Longer Afford to Ignore

The stakes behind this regulatory shift are not abstract. Argentina carries one of the highest tobacco-attributable mortality burdens in Latin America. A peer-reviewed modelling study published in Nicotine & Tobacco Research (Oxford Academic, February 2026) estimated that approximately 55,700 smoking-attributable deaths occur in Argentina annually, and that over 4 million deaths and 79 million life years lost due to smoking are projected from 2000 to 2100 under a status-quo scenario. Even if all smoking were to cease immediately, the study found, the legacy burden would still account for 49 million lost life years, representing a maximum preventable burden of 30 million years, or 38% of total projected smoking-related mortality.

This is the public health emergency that Argentina’s smoke-free policy must address. And the evidence is increasingly clear that regulated nicotine alternatives including ENDS, heated tobacco, and nicotine pouches, are meaningful tools in that effort.

The Science of Smoke-Free: What the Evidence Says About ENDS

The harm reduction case for regulated nicotine alternatives rests on a growing and now substantial body of clinical evidence. The 2024 Cochrane systematic review, one of the most rigorous independent reviews in medical science, concluded that nicotine e-cigarettes help people quit smoking for at least six months and that they outperform traditional nicotine replacement therapy (NRT) including patches and gum. The New England Journal of Medicine, commenting on that Cochrane review, stated that ‘the evidence now supports a strong conclusion that e-cigarettes are tools that clinicians can use to help adults stop smoking, especially those who are unable to quit with current evidence-based treatments.’

This position has been reinforced by the updated 2025 Cochrane living systematic review, which has continued to add primary studies and affirms the core finding: regulated nicotine-containing e-cigarettes are more effective than NRT and show no detected evidence of serious harm in trials. The National Institute on Drug Abuse (NIDA) at the US National Institutes of Health noted in September 2025 that vaping does not present the worst health risks associated with combustible tobacco and that it can facilitate smoking cessation, which is a position that has shifted from tentative endorsement to clinical confidence over the past five years.

The distinction between product categories also matters. Argentina’s Resolution 549/2026 makes an explicit regulatory acknowledgement that nicotine pouches do not generate third-party exposure in the same manner as combustible or inhaled products, which is a formal recognition of risk differentiation that the Global Institute for Novel Nicotine has described as ‘one of the clearest examples to date in Latin America of formal risk differentiation being incorporated into national health regulation.’ This is precisely the kind of evidence-based, product-specific policy thinking that leads to better public health outcomes.

Why Compliance Is the Foundation of Any Smoke-Free Future

Argentina’s experience under prohibition is a textbook case of why enforcement matters more than intent. For over a decade, vaping products were banned. And for over a decade, they were sold in kiosks, online, and through informal networks without registration, without ingredient disclosure, without age verification, and without any quality standard. The SEDRONAR 2025 survey’s finding that 35.5% of secondary school students had used e-cigarettes or vaping products under prohibition is not evidence that vaping products are impossible to regulate. It is evidence that prohibition, unaccompanied by enforcement infrastructure, produces the worst of all outcomes: unregulated access for everyone, including children.

Resolution 549/2026 is the Argentine government’s acknowledgement of this reality. As the Tobacco Reporter noted in its coverage of the resolution, the new framework requires traceability, quality standards and mandatory registration for all manufacturers and retailers operating in the country. This is exactly the compliance architecture that distinguishes responsible market participants from grey-market operators, and it is the architecture that AIRSCREAM has built its entire operating model around.

AIRSCREAM’s position on compliant markets is unambiguous: we operate where we can operate transparently, with full regulatory compliance, in partnership with credible, accountable distributors and retailers. We do not seek regulatory ambiguity. We do not operate in grey zones. We view every regulatory framework including one as newly minted as Argentina’s, as an opportunity to demonstrate what responsible industry participation looks like in practice: product registration, supply chain traceability, age verification, and ingredient transparency from day one.

AIRSCREAM’s Commitment

AIRSCREAM was built on the operating principle that compliance is not a constraint on our business, it is the business. In every market we enter, we bring the same framework of registered products, documented supply chains, vetted distribution partners, and a genuine commitment to keeping nicotine products out of the hands of minors.

Argentina’s Resolution 549/2026 represents the kind of regulatory clarity we welcome. We are watching the market’s development carefully, with the same approach we bring to every emerging regulated market: patience, rigour, and no shortcuts.

For the 8.1 million Argentine adults who smoke, the most important thing about this moment is not which brand enters the market first. It is whether the regulatory framework holds, whether registration, traceability, and enforcement are real, not aspirational. That is the question that will determine whether Argentina’s smoke-free ambition becomes a public health achievement or another policy that looks good on paper.

We believe it can be the former. And we will be a part of making it so.

Sources:

1. Argentina Ministry of Health, Resolution 549/2026 (Official Gazette, 4 May 2026); ANMAT Provision 2543/2026.
2. We Are Innovation (WAI), ‘Argentina Ends Years of Prohibition and Creates a Regulatory Framework For Innovative Nicotine Products,’ 4 May 2026. weareinnovation.global
3. 2FIRSTS, ‘Argentina Issues Resolution 549/2026 to Regulate Vapes, Heated Tobacco and Nicotine Pouches,’ 6 May 2026. 2firsts.com
4. Tobacco Reporter, ‘Argentina Lifts Alternative Product Ban, Imposes New Regs,’ 6 May 2026. tobaccoreporter.com
5. Global Institute for Novel Nicotine (GINN), ‘Argentina Rewrites Its Nicotine Policy Framework: From Prohibition to Regulatory Integration,’ May 2026. ginn.global
6. Fundeps, ‘Setback for Public Health: Argentina Authorizes the Commercialization of Electronic Cigarettes and Heated Tobacco Products,’ May 2026. fundeps.org
7. Global State of Tobacco Harm Reduction (GSTHR), ‘Tobacco Smoking in Argentina,’ updated October 2025. gsthr.org; citing WHO Global Report on Trends in Prevalence of Tobacco Use 2000–2024, 6th Edition, 2025.
8. Nicotine & Tobacco Research (Oxford Academic), ‘Modeling the Impact of Smoking on Mortality in Argentina From 2000 to 2100,’ February 2026. doi:10.1093/ntr/ntad180
9. Cochrane Library (Living Systematic Review), Lindson N et al., ‘Electronic cigarettes for smoking cessation,’ updated November 2025. doi:10.1002/14651858.CD010216.pub10
10. New England Journal of Medicine, ‘Electronic Cigarettes for Smoking Cessation — Have We Reached a Tipping Point?’ January 2024. doi:10.1056/NEJMe2314977
11. National Institute on Drug Abuse (NIDA/NIH), ‘Toward the Development of E-cigarettes as Smoking-Cessation Therapeutics,’ September 2025. nida.nih.gov
12. The Lancet Regional Health – Americas, ‘Smoking Patterns by Birth Cohort in Argentina: An Age-Period-Cohort Population-Based Modelling Study,’ June 2024. doi:10.1016/j.lana.2024.100812
13. Tobacco Atlas, ‘Argentina Factsheet,’ 2024. tobaccoatlas.org
14. Aduananews, ‘Argentina Redefines the Tobacco and Nicotine Regime with New Rules, Controls and Increased Tariffs,’ May 2026. aduananews.com